Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects

NCT: NCT04674826 · COMPLETED

NCT IDNCT04674826
StatusCOMPLETED
Start Date2021-02-08
Completion2021-12-29

Brief Summary

The purpose of this trial is to compare the pharmacokinetics (PK), safety, tolerability and immunogenicity of a single dose of 300 mg tralokinumab administered as a 1 × X mL subcutaneous (SC) injection with Device A and 2 × Y mL consecutive SC injections with Device B.

Frequently Asked Questions

What is A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects?

A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects is a clinical trial registered under NCT04674826. Current status: COMPLETED.

What is the status of NCT04674826?

The current status of NCT04674826 (A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects) is: COMPLETED.

When did A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects start?

A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects started on 2021-02-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑